Skip to main content

Table 3 Past medical history of the study's participants

From: Compliance with the north American Society of Pacing and Electrophysiology guidelines on amiodarone monitoring in Riyadh, Saudi Arabia: a retrospective charts review study

Comorbidity N (%)

Hypertension

Lung disease

108 (75.5)

32 (22.4)

Diabetes mellitus

Renal disease

94 (65.7)

49 (34.3)

Dyslipidemia

Liver disorder

48 (33.6)

11 (7.7)

Myocardial infraction

Malignancy

47 (32.9)

18 (12.6)

Coronary artery disease

Gout

89 (62.2)

2 (1.4)